Skip to main content

Table 3 The 10-year disease-free survival rates and univariate Cox regression analysis

From: The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery

Factors

disease-free survival rates

Hazard ratio

 

Log-rank test

p-value

 

10-year (%)

95% CI a

 

95% CI a

 

Age

     

   < 35

47.0

33.3–60.7

1.00

-

0.49

   35–54

59.0

55.7–62.4

0.91

0.50–1.64

 

   ≥ 55

63.1

59.4–66.7

0.90

0.50–1.63

 

cTNM

     

   Stage I

72.4

67.3–77.6

1.00

-

<0.001

   Stage II

60.9

58.0–63.9

2.05

1.45–2.91

 

   Stage III

31.5

24.8–38.2

5.03

3.36–7.52

 

pTNM

     

   Stage I

81.7

77.4–85.9

1.00

-

<0.001

   Stage II

67.5

64.4–70.5

2.18

1.47–3.24

 

   Stage III

17.7

13.1–22.4

7.66

5.13–11.43

 

pN

     

   pN0

76.6

73.8–79.5

1.00

-

<0.001

   pN1

56.4

51.6–61.2

1.85

1.36–2.53

 

   pN2

15.5

10.3–20.7

5.75

4.22–7.83

 

   pN3

26.8

16.6–37.1

4.88

3.25–7.32

 

ER status

     

   Negative

59.8

56.4–63.2

1.00

-

0.183

   Positive

60.0

56.6–63.4

0.83

0.63–1.09

 

Breast surgery

     

   Breast conserving surgery

59.1

54.1–64.0

1.00

-

0.007

   Modified radical mastectomy

61.5

58.7–64.3

1.14

0.86–1.52

 

   Standard radical mastectomy

NDb

-

3.34

1.76–6.33

 
  1. a CI: Confidence interval,b ND: not determined.